Pathogenesis of dilated cardiomyopathy and heart failure: insights from cell morphology and biology

S Hein1, J Schaper

  • 1Max Planck Institute, Kerckhoff Clinic for Cardiac Surgery, Bad Nauheim, Germany.

Insights

Dilated cardiomyopathy likely stems from multiple causes, including genetic defects and immune responses. Further research using cell models and animal studies is crucial for understanding its complex mechanisms.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • The etiology of dilated cardiomyopathy (DCM) remains largely unknown, suggesting a multifactorial origin.
  • Emerging evidence points to chromosomal aberrations and autoantibodies as potential contributors to DCM pathogenesis.
  • Current understanding involves impaired calcium handling, reduced beta-adrenergic receptor function, myocyte enlargement with degenerative changes, and fibrosis.

Purpose of the Study:

  • To explore the complex and evolving pathogenetic mechanisms underlying dilated cardiomyopathy.
  • To highlight the potential role of titin defects in sarcomere formation disturbances in DCM.
  • To emphasize the utility of novel animal models and cell culture systems for advancing DCM research.

Main Methods:

  • Review of current knowledge on DCM pathogenesis.
  • Investigation of potential genetic factors, including chromosomal aberrations and titin defects.
  • Discussion of cellular mechanisms such as sarcoplasmic reticulum calcium uptake and beta-receptor density.
  • Consideration of advanced research models including animal studies and adult cardiac myocyte cultures.

Main Results:

  • The pathogenesis of DCM is multifactorial, involving genetic and autoimmune components.
  • Key cellular dysfunctions include impaired calcium uptake, reduced contractility, myocyte hypertrophy, and fibrosis.
  • Defects in the sarcomeric protein titin are implicated in disturbed sarcomere assembly.

Conclusions:

  • Dilated cardiomyopathy arises from a combination of genetic predispositions and potential autoimmune factors.
  • Understanding the intricate molecular and cellular mechanisms is essential for therapeutic development.
  • Advanced research models are critical for future progress in deciphering DCM pathology.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...